Guillaume Raux has over 15 years of experience in global Clinical & Regulatory affairs in the fields of Cardiac Rhythm Management, Electrophysiology, Cardiovascular, and Neuromodulation. Guillaume spent 6.5 years at Nyxoah leading the Clinical & Regulatory affairs teams in Europe, Australia, and the US. Guillaume played a key role in obtaining the Genio CE mark, an expanded indication for the therapy, the approval of the US IDE study while helping the company to go public. Prior to Nyxoah, Guillaume held various roles at St Jude Medical. Guillaume holds a Ph.D. in Electrical Engineering from Texas A&M University.